Skip to main content
OpenTrials

Clinical trial condition

Paroxysmal Nocturnal Hemoglobinuria

Explore clinical trials studying Paroxysmal Nocturnal Hemoglobinuria. Study availability and eligibility vary by location and protocol.

89 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Paroxysmal Nocturnal Hemoglobinuria trial results

Recruiting

A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

NCT05744921

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Toronto General Hospital Toronto, Ontario, Canada
  • Hospital Pablo Tobon Uribe Medellín, Antioquia, Colombia
  • Semmelweis University/Semmelweis Egyetem Budapest, Hungary
  • Amrita Institute of Medical Sciences (AIMS) and Research Centre Aims Kochi, Kerala, India
View all 46 locations
View Trial Details
Recruiting

A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently

NCT07154745

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Hospital das Clinicas da FMRP USP Ribeirão Preto, São Paulo, Brazil
  • Faculdade de Medicina do ABC Santo André, São Paulo, Brazil
  • CISSS-CA Lévis, Quebec, Canada
  • Universita Cattolica del Sacro Cuore - Policlinico Universitario A. Gemelli Rome, Lazio, Italy
View all 19 locations
View Trial Details
Recruiting

A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT05776472

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Sunshine Coast University Hospital Birtinya, Queensland, Australia
  • Canberra Hospital Garran, Australia
View all 87 locations
View Trial Details
Recruiting

A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China

NCT06931691

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Novartis Investigative Site Hefei, Anhui, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Shijiazhuang, Hebei, China
View all 14 locations
View Trial Details

Related conditions